Olivia’s story diagnosed with TFE3-related neurodevelopmental disorder
3billion Inc reflects Dr. Alisdair McNeill’s latest finding on genetic variants to end diagnostic odyssey
3billion announced this May 10th Dr. Hane Lee of UCLA to direct their genetic laboratory.
Vertebral, cardiac, tracheoesophageal, renal, and limb defects (VCTERL) is a rare genetic disorder characterized by congenital heart disease, abnormal vertebral morphology, renal abnormalities, and limb abnormalities.
3billion is on track to go public by early 2022; with further ambitions to expand into novel drug discovery.
Diagnosis story of a girl diagnosed with Vertebral, cardiac, tracheoesophageal, renal, and limb defects (VCTERL)
Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked (IPEX) is a rare genetic disorder characterized by multiple autoimmune symptoms in organs.
3billion has closed its Series C funding round raising $13 million, a total of $30 million since its seed round in 2017.